Skip to main content
Top

Cardiovascular Drugs and Therapy

Issue 3/2023

Content (19 Articles)

Open Access Ventricular Fibrillation Original Article

The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

Guanghui Zheng, Fenglian He, Jing Xu, Juntao Hu, Weiwei Ge, Xianfei Ji, Changsheng Wang, Jennifer L. Bradley, Mary Ann Peberdy, Joseph P. Ornato, Longyuan Jiang, Stefano Toldo, Tong Wang, Wanchun Tang

Empagliflozin Original Article

Empagliflozin Ameliorates Ouabain-Induced Na+ and Ca2+ Dysregulations in Ventricular Myocytes in an Na+-Dependent Manner

Xiaodong Peng, Linling Li, Rong Lin, Xuesi Wang, Xinmeng Liu, Yukun Li, Changsheng Ma, Yanfei Ruan, Nian Liu

Clopidogrel Original Article

Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

Shuang Zhou, Zhe Wang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Zining Wang, Qian Xiang, Yanjun Gong, Yimin Cui

A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients

Amir Kazerouninia, Justin Georgekutty, Payton Kendsersky, Ryan D. Byrne, Brendan Seto, Patricia Y. Chu, Yunfei Wang, Fred H. Rodriguez III, Clayton Smith, Anita Saraf, Michael S. Lloyd, Benjamin P. Frischhertz, Dhaval R. Parekh, Peter R. Ermis, Wayne J. Franklin, Wilson W. Lam

Carvedilol Original Article

Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study

Chan Soon Park, Jin Joo Park, Hae-Young Lee, Seok-Min Kang, Byung-Su Yoo, Eun-Seok Jeon, Suk Keun Hong, Joon-Han Shin, Myung-A. Kim, Dae-Gyun Park, Eung-ju Kim, Soon-jun Hong, Seok Yeon Kim, Jae-Joong Kim, Dong-Ju Choi

Atrial Fibrillation Original Article

Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation

Qiqi Wang, Chengui Zhuo, Qi Xia, Jiajia Jiang, Bifeng Wu, Dongchen Zhou, Zheyue Shu, Jianqiang Zhao, Miao Chen, Heng Chen, Zewei Sun, Biqi Zhang, Jie Han, Liangrong Zheng

Open Access Stroke Original Article

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong

Sharen Lee, Jiandong Zhou, Keith Sai Kit Leung, Abraham Ka Chung Wai, Kamalan Jeevaratnam, Emma King, Tong Liu, Wing Tak Wong, Carlin Chang, Ian Chi Kei Wong, Bernard Man Yung Cheung, Gary Tse, Qingpeng Zhang

Arterial Occlusive Disease Invited Review Article

NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases

Weijia Cheng, Can Cui, Gang Liu, Chenji Ye, Fang Shao, Ashim K. Bagchi, Jawahar L. Mehta, Xianwei Wang

Alirocumab Invited Review Article

Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review

S. Bellosta, C. Rossi, A. S. Alieva, A. L. Catapano, A. Corsini, A. Baragetti

Statins Invited Editorial

Great Drugs, If You Could Just Get Patients to Take Them

Reed Otten, James C. Blankenship

Atrial Fibrillation Short Communication

Model-Based Risk Prediction of Rivaroxaban with Amiodarone for Moderate Renal Impaired Elderly Population

Ziteng Wang, Eleanor Jing Yi Cheong, Pipin Kojodjojo, Eric Chun Yong Chan